课题基金 / 基金详情

Engineering and Analysis of T cell CD3 and IL2R Signals

Engineering and Analysis of T cell CD3 and IL2R Signals
T 细胞 CD3 和 IL2R 信号的工程和分析
批准号:
6960613
负责人:
Karl Dane Wittrup
金额:
$51.75万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-15 至 2009-02-28

项目摘要

项目成果

Karl Dane Wittrup的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):该项目为T细胞反应的建模和分析提供了一个独特的合作机会。定量了解CDS和IL-2R信号输入如何联合设置生长/死亡二元开关,对于优化癌症、病毒感染和自身免疫性疾病的免疫治疗策略至关重要。我们建议在培养的原代人T细胞中构建静息、激活、能量和凋亡的离散状态之间转换的预测动态模型。这些研究的系统视角是线索/信号/反应。细胞外信号、细胞内信号和人类T细胞对CDS和IL-2R刺激的整体反应将通过应用实验和计算领域的最先进的合成和分析方法进行解析。这些线索将由抗cds抗体模拟物和高亲和力的IL-2突变体组成,这些突变体通过定向进化来提供定量控制的系统输入。信号将在几个细节水平上进行跟踪:在单细胞水平上,通过对关键信号分子的多维流式细胞术测量;Western blot和激酶检测在群体水平上;通过质谱分析在磷蛋白质组水平上。贝叶斯推断将应用于从多变量流式细胞术和质谱法获得的磷酸化蛋白质组数据构建影响网络,偏最小二乘分析将用于状态识别,信号通路的动力学建模将用于描述和预测线索和信号之间的动态关系。该合作项目将整合蛋白质工程(KDW)、理论和系统生物学(DAL)、磷蛋白质组质谱(FW)以及细胞免疫学和流式细胞术(GPN)方面的专业知识。这些研究将提供对T细胞调控的见解,并开发具有潜在治疗价值的CDS和IL-2刺激分子。
英文摘要
DESCRIPTION (provided by applicant): This project represents a unique collaborative opportunity for the modeling and analysis of T cell responses. A quantitative understanding of how CDS and IL-2R signal inputs combine to set the binary growth/death switch is critical for optimizing immunotherapeutic strategies in cancer, viral infection, and autoimmune diseases. We propose to construct predictive dynamic models of transitions between the discrete states of resting, activation, anergy, and apoptosis in cultured primary human T cells. The systems perspective framing these studies is cue/signal/response. The extracellular cues, intracellular signals, and overall responses of human T cells to CDS and IL-2R stimulation will be parsed by the application of state-of-the-art synthetic and analytical methodologies from both the experimental and computational realms. The cues will consist of anti-CDS antibody mimics and high affinity IL-2 mutants engineered by directed evolution to provide quantitatively controlled system inputs. Signals will be tracked at several levels of detail: at the single-cell level by multidimensional flow cytometric measurements of the key signaling molecules; at the population level by Western blot and kinase assay; and at the phosphoproteome level by mass spectrometry. Bayesian inference will be applied to construct influence networks from phosphoproteome data obtained with multivariate flow cytometry and mass spectrometry, partial least squares analysis will be utilized for state identification, and kinetic modeling of signaling pathways will be used to describe and predict the dynamic relationships between cues and signals. This collaborative project will integrate expertise in protein engineering (KDW), theoretical and systems biology (DAL), phosphoproteome mass spectrometry (FW), and cellular immunology and flow cytometry (GPN). These studies will provide insights into T cell regulation as well as develop CDS and IL-2 stimulatory molecules of potential therapeutic value.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Localizing Immunotherapy to Improve Therapeutic Index
Localizing Immunotherapy to Improve Therapeutic Index
Localizing Immunotherapy to Improve Therapeutic Index
Foundations of Pretargeted Radioimmunotherapy
海外基金